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Role for formin-like 1-dependent acto-myosin
assembly in lipid droplet dynamics and lipid storage
Simon G. Pﬁsterer1,2, Gergana Gateva3, Peter Horvath4,5, Juho Pirhonen1,2, Veijo T. Salo1,2, Leena Karhinen1,
Markku Varjosalo3, Samppa J. Ryha¨nen6, Pekka Lappalainen3 & Elina Ikonen1,2
Lipid droplets (LDs) are cellular organelles specialized in triacylglycerol (TG) storage
undergoing homotypic clustering and fusion. In non-adipocytic cells with numerous LDs this
is balanced by poorly understood droplet dissociation mechanisms. We identify non-muscle
myosin IIa (NMIIa/MYH-9) and formin-like 1 (FMNL1) in the LD proteome. NMIIa and actin
ﬁlaments concentrate around LDs, and form transient foci between dissociating LDs. NMIIa
depletion results in decreased LD dissociations, enlarged LDs, decreased hydrolysis and
increased storage of TGs. FMNL1 is required for actin assembly on LDs in vitro and for NMIIa
recruitment to LDs in cells. We propose a novel acto-myosin structure regulating lipid
storage: FMNL1-dependent assembly of myosin II-functionalized actin ﬁlaments on
LDs facilitates their dissociation, thereby affecting LD surface-to-volume ratio and enzyme
accessibility to TGs. In neutrophilic leucocytes from MYH9-related disease patients NMIIa
inclusions are accompanied by increased lipid storage in droplets, suggesting that NMIIa
dysfunction may contribute to lipid imbalance in man.
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I
n cells, lipid droplets (LDs) are highly dynamic,
well-connected with other organelles and actively commu-
nicating with one another1–3. LDs undergo major
morphological changes depending on the metabolic status of
cells. In energy surplus, stimulation of triacylglycerol (TG)
storage results in LD enlargement, apparently by both fusion
and lipid transfer between adjacent LDs4,5, with the extreme
phenotype being unilocular LDs in mature adipocytes. The
homotypic fusion of LDs is regulated by Fsp27 enriched at LD
contact sites and its activity is controlled by Rab8a6. Conversely,
TG breakdown by lipolysis is accompanied by LD shrinkage,
dissociation and dispersion7. This process involves modiﬁcation
of LD resident proteins to allow docking and activation of
lipolytic enzymes to digest the lipid core8, and eventual dispersion
of smaller LDs to the cell periphery in a microtubule-dependent
fashion7,9. How the initial dissociation of adjacent LDs is
achieved, is essentially unknown.
Actin and actin-binding proteins have been reported to be
associated with LDs10–12. In murine macrophages, pharma-
cological disruption of the actin cytoskeleton reduces LD size and
lipid storage10 and in 3T3-L1 cells, inhibition of actin dynamics
through coﬁlin-1 depletion disrupts adipogenesis and lipid
storage13. At the organismal level, pharmacological perturbation
of acto-myosin turnover in zebraﬁsh affects the recruitment of
LDs from the yolk-blastodisc to the animal pole14. However,
whether LDs associate with speciﬁc actin ﬁlament structures and
what functional role they may have, has not been deﬁned.
Here, we provide evidence for the presence of a novel acto-
myosin structure that associates with LDs to control their
dynamics. We show that the actin-binding protein formin-like 1
(FMNL1) facilitates the assembly of non-muscle myosin IIa
(NMIIa) containing actin ﬁlament arrays on LDs. Importantly,
depletion of NMIIa from human cells reduces LD dynamics
and alters their clustering propensity, resulting in supersized
LDs and reduced TG hydrolysis. Together, these data suggest
that NMIIa assembling with actin in focal points around
LDs assists in the dissociation of clustered LDs.
Results
NMIIa depletion results in enlarged LDs and increased TGs.
We conducted a proteomic proﬁling of LD-associated proteins. This
revealed several actin-binding proteins (Supplementary Table 1),
including NMIIa (encoded by the MYH9 gene), a structural
component of contractile actin ﬁlaments. NMIIa has earlier been
identiﬁed in the LD proteome of several organisms10–12, but its
functional role at LDs remains unknown.
To investigate the role of NMIIa at LDs, we silenced the protein
from human osteosarcoma U2OS cells (Supplementary Fig. 1a–d),
a cell line commonly used for studying cytoskeletal dynamics. For
systematic analysis of LDs in U2OS cells, we developed automated
image analysis tools to quantify LD abundance, size and clustering
(Supplementary Fig. 2a). Under normal growth conditions, roughly
100 LDs were detected in these cells using ﬂuorescent LD dyes, with
small LDs (below 0.5mm2) representing the overwhelming majority
(Fig. 1a,b, Supplementary Fig 2b,c). Oleic acid administration
for 7 h roughly doubled the number of LDs (Supplementary
Fig. 2b), whereas their relative size distribution was not changed
(Supplementary Fig. 2c). Interestingly, depletion of NMIIa resulted
in a LD rearrangement with larger LDs being signiﬁcantly increased
(about sixfold for LDs between 0.5 and 1.0mm2 and ninefold for
LDs in the range of 1.5–2mm2; Fig. 1a,b). A similar increase in
LD size was observed upon oleic acid administration in
NMIIa-depleted cells (Fig. 1c,d). Enhanced formation of large
LDs was also observed with another NMIIa-targeting siRNA,
suggesting that the effect is speciﬁc (Supplementary Fig. 2d).
To further assess the speciﬁcity of the LD enlargement upon
NMIIa depletion, we generated U2OS cells stably overexpressing
an siRNA-resistant Cherry-NMIIa, or Cherry alone as control
(Fig. 1e,f). We found that the accumulation of enlarged LDs upon
NMIIa depletion was rescued by Cherry-NMIIa overexpression in
control conditions (Fig. 1e,f) as well as upon oleic acid loading
(Supplementary Fig. 2e). Conversely, NMIIa overexpression
in control cells resulted in the reduction of large LDs (Fig. 1f).
In addition, acute inhibition of NMIIa ATPase activity for 1 h
with blebbistatin15 showed a similar tendency toward enlarged
LDs (Supplementary Fig. 2f). Together, these data provide
additional evidence that the LD enlargement is a speciﬁc effect
of NMIIa loss.
We next explored whether depletion of NMIIa affects
neutral lipid storage. We found that the larger size of LDs in
NMIIa-depleted cells was accompanied by a signiﬁcant
increase in TG deposition compared to control cells (Fig. 1g). A
similar effect was obtained upon NMIIa inhibition with
blebbistatin (Fig. 1h). The increased TG content was due to
impaired TG breakdown rather than increased TG synthesis,
as in NMIIa-silenced cells, TG hydrolysis was reduced
(Fig. 1i) but TG synthesis was unaffected (Fig. 1j). This is in
line with the idea that the lower surface-to-volume ratio
in larger LDs reduces the accessibility of hydrolytic enzymes to
droplets16.
Importantly, general disruption of NMIIa-positive stress ﬁbres
through inhibition of the small GTPase Rho in ﬁlopodia or
silencing of tropomyosin 4 (ref. 17) did not increase the
proportion of large LDs in either control or oleic acid loaded
conditions (Supplementary Fig. 3). These data argue that the
observed LD phenotypes in NMIIa-depleted cells are not
due to problems in stress ﬁbre assembly, but rather that
NMIIa contributes to LD dynamics through a more speciﬁc
mechanism.
NMIIa localizes transiently to LD dissociation sites. We
investigated the localisation of NMIIa at LDs using confocal and
three-dimensional structured illumination microscopy (3D-SIM).
To facilitate this, we employed mild saponin permeabilization of
cells prior to ﬁxation, to reduce the cytoplasmic pool of NMIIa
(Supplementary Fig. 1e,f). We found that endogenous NMIIa
localized to focal points around LDs visualized
by the LD marker peptide HPOS18-Cherry stably expressed in
U2OS cells (Fig. 2a,b), whereas the periodic labelling pattern of
NMIIa along stress ﬁbres was preserved (Fig. 2b). The LD-
associated NMIIa patches often located between two neighbouring
LDs or between clustered LDs (Fig. 2a,b, Supplementary Fig. 1g–k).
On average, LDs were associated with three NMIIa patches and
approximately one patch per LD–LD contact site (Supplementary
Fig. 1g,h). Also ﬁlamentous actin (F-actin) was found at LDs and
LD–LD contact sites and a subset of this actin colocalized
with endogenous NMIIa at LDs (Fig. 2b, Supplementary Fig. 1i).
For more detailed investigation of NMIIa localisation at LDs we
used immuno-electron microscopy. This recapitulated, in addition
to the expected periodic NMIIa immunoreactivity along stress
ﬁbres, NMIIa on the surface of individual LDs and at LD–LD
contact sites (Fig. 2c).
To monitor NMIIa dynamics at LDs in living cells, we used
Airyscan superresolution microscopy of GFP-NMIIa-expressing
cells. This revealed distinct GFP-NMIIa patches transiently
concentrating between clustered LDs (Fig. 2d, Supplementary
Movie 1; for additional examples, see Supplementary Fig. 4a,
Supplementary Movies 2 and 9). In many cases, transient NMIIa
accumulation between two LDs was followed by their dissociation
(Fig. 2d, Supplementary Movie 1). Plotting of NMIIa and
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LD intensity proﬁles of dissociating LDs before NMIIa accumula-
tion, upon NMIIa enrichment and after LD segregation, showed
a transient increase in NMIIa ﬂuorescence during the partitio-
ning of LDs (Fig. 2e, Supplementary Fig. 4b). Furthermore, we
observed transient accumulation of ﬂuorescently tagged actin
between dissociating LDs (Supplementary Fig. 4c,d and
Supplementary Movie 3), suggesting that NMIIa and actin
ﬁlaments cooperate in the dissociation of LDs.
NMIIa affects LD dissociation dynamics and LD clustering. To
address if the loss of NMIIa affects LD dynamics, we monitored
the association kinetics of clustered LDs, that is, LDs that
were associated with each other. Coherent anti-stokes Raman
scattering (CARS) microscopy was employed for label-free
imaging of LDs in live cells (Fig. 3a,b, Supplementary Movie 4).
This revealed that in control cells, the clustered LDs either stayed
associated with each other (static clusters) or were highly
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dynamic, with rapid association and dissociation of the
clustered LDs during the 5min recording (Fig. 3a, Supplementary
Movie 4). Interestingly, in NMIIa-depleted cells, static LD
associations were more prevalent (Fig. 3b, Supplementary
Movie 4). Similar observations were made upon NMIIa inhibi-
tion with blebbistatin or disruption of actin polymerisation
with cytochalasin D (Supplementary Movies 5 and 6). Analo-
gously to blebbistatin, acute cytochalasin D treatment increased
the proportion of larger LDs (Supplementary Fig. 2g). Owing to
the similar effects of NMIIa depletion and blebbistatin on
LDs, the motor activity of myosin II appears functionally
important, and other myosin isoforms, including NMIIb,
seem not to fully compensate for the loss of NMIIa.
To obtain further quantitative information on the altered
LD association characteristics upon NMIIa depletion, we
extended the automated LD detection pipeline with a cluster
analysis tool (Fig. 3c). This tool considers LDs to be clustered
if the distance between droplet boundaries is smaller or equal
to two pixels (0.266mm), enabling the detection of clusters with
a variable LD number and quantiﬁcation of average LD sizes
as well as LD size heterogeneity within clusters. In control
cells loaded with oleic acid, the majority of LD clusters comprised
two droplets, followed by a decreasing abundance of clusters
containing more droplets (Fig. 3d). Interestingly, NMIIa-depleted
cells loaded with oleic acid contained overall less-clustered LDs,
with most pronounced reductions for clusters of three and
four LDs (Fig. 3d). In parallel, the mean size of clustered
LDs increased by B75% upon NMIIa silencing (Fig. 3e) and
their size heterogeneity increased, as evidenced by greater
than threefold increase in the s.d. of the size of clustered
LDs (Fig. 3f,g). The observed changes in the size of clustered
LDs were due to loss of NMIIa, as they were reversed in cells
overexpressing the siRNA-resistant Cherry-NMIIa (Fig. 3h,i).
These results indicate that NMIIa depletion results in reduced
motility of associated LDs and a larger size heterogeneity between
associated LDs. Moderate alterations in the balance of
LD dissociation/re-association may over time result in prominent
LD size changes, with bigger LDs deriving from coalescence
of neighbouring LDs, as suggested by the observed fusion
between immotile, clustered LDs (Supplementary Fig. 4e,f,
Supplementary Movie 7).
FMNL1 localizes to LD dissociation sites. Our proteomic
analysis also revealed the actin regulatory protein FMNL1 among
the LD-associated proteins (Supplementary Table 1). FMNL1
has several activities, such as stimulation of actin polymerisation
and bundling of actin ﬁlaments19,20, providing a candidate to
drive the formation of actin ﬁlaments at LDs. We therefore
investigated the localisation of endogenous FMNL1 in U2OS cells
using Airyscan and 3D-SIM imaging. FMNL1 antibodies revealed
punctate cytoplasmic as well as perinuclear immunoreactivity,
in agreement with previous studies21. To reduce cytoplasmic
immunoreactivity, cells were saponin permeabilized pre-ﬁxation,
similarly as for NMIIa staining (Supplementary Fig. 5d,e).
This highlighted punctate FMNL1 labelling on the surface of
LDs (Fig. 4a,b). We found on average three FMNL1 patches
associated per LD and of these approximately half localized to
LD–LD contact sites (Supplementary Fig. 5f,g). Interestingly,
FMNL1 patches at LDs were closely apposed to NMIIa dots, as
visualized by myosin light chain staining (Fig. 4c, Supplementary
Fig. 5h). Live cell Airyscan video microscopy demonstrated that
GFP-FMNL1 localized transiently to LD dissociation sites
(Fig. 4d, Supplementary Movie 8). Of the 155 LD dissociation
events quantiﬁed, over 60% showed FMNL1 foci between
the dissociating LDs (Fig. 4f) and in nearly all of them, FMNL1
was present already before the separation of LDs occurred
(Fig. 4g). When a similar analysis was performed from live cell
Airyscan videos of GFP-NMIIa expressing cells, we observed
about half of the LD dissociation sites to contain NMIIa
accumulations (Fig. 4e,f; Supplementary Movie 9). Interestingly,
NMIIa seemed to be recruited to the dissociation sites after
FMNL1, as in B1/3 of the events the NMIIa accumulation
appeared once LDs had started to separate from each other
(Fig. 4g). We also noted that after dissociation some
LDs underwent reassociation and that FMNL1 could stay
associated with LDs during such events (Supplementary Fig. 6
Supplementary Movies 10 and 11).
To investigate the interrelationship of FMNL1 and actin upon
LD dissociation, we performed triple-colour live cell Airyscan
imaging of GFP-FMNL1, BFP-Lifeact and LDs in a region
below the nucleus, to minimize cytoplasmic background (Fig. 5a).
This revealed a transient focal accumulation of GFP-FMNL1
in a LD cluster, followed by dynamic accrual of BFP-Lifeact
between dissociating LDs (Fig. 5b,c; Supplementary Movie 12).
We also monitored the accumulation of a larger FMNL1
patch apparently driving the separation of neighbouring
LDs (Fig. 5d–f; Supplementary Movie 13). This enabled focal
intensity measurements of FMNL1 and Lifeact, further substan-
tiating the idea that an increase in FMNL1 intensity preceeded
that of Lifeact between LDs (Fig. 5f).
FMNL1 drives actin assembly on LDs and recruits NMIIa to LDs.
Together, these data suggest that FMNL1 can generate
actin ﬁlaments on LDs, which in turn may recruit NMIIa. In
support of this idea, we found a major reduction of NMIIa in
LD fractions of FMNL1-silenced cells (Fig. 6a–c; Supplementary
Fig. 7f,g). This was accompanied by a decrease of NMIIa
immunostaining at LDs upon FMNL1 depletion (Supplementary
Figure 1 | NMIIa depletion results in enlarged LDs and increased TG deposition. (a) LD morphology of U2OS cells treated with control or NMIIa siRNA.
Cells were stained with LipidTOX green (LDs), DAPI (nuclei) and CellTracker Red (cytoplasm, not shown). (b) Automated LD quantiﬁcation of U2OS cells
treated as in a,±s.e.m., n¼ 303 cells for siCtrl and 228 cells for siNMIIa from three independent experiments. (c) Similar as in a with 200mM oleic acid
treatment for 7 h. (d) Automated LD quantiﬁcation of cells treated as in c. ±s.e.m. n¼ 293 cells for siCtrl and 204 cells for siNMIIa, from three
independent experiments. (e) LD morphology of U2OS cell lines expressing either Cherry or siRNA resistant Cherry-NMIIa (Cherry-NMIIa siRes) and
treated with NMIIa siRNA. Cells were stained with LD540 (LDs), DAPI (nuclei) and CellTracker Red (cytoplasm, not shown). (f) Automated LD
quantiﬁcation of cells treated as in e, ±s.e.m. n¼ 339 for Cherry siCtrl, 261 cells for Cherry siNMIIa, n¼ 303 cells for Cherry NMIIa siRes siCtrl
and 270 cells for Cherry NMIIa siRes siNMIIa, from 3 independent experiments. (g) TG amount of U2OS cells treated with siCtrl or siNMIIa
(±s.e.m., n¼ 6–7 samples from three independent experiments). (h) TG amount of U2OS cells treated with or without 30mM Blebbistatin for 24 h
(±s.e.m., n¼ 5 samples from two independent experiments). (i) TG hydrolysis in U2OS cells treated with siCtrl or siNMIIa. Cells were treated with
200mM oleic acid overnight to induce TG storage followed by incubation in complete medium for 8 h to induce TG hydrolysis (±s.e.m., n¼ 8 samples
from four independent experiments). (j) TG synthesis as measured by 3H-oleic acid incorporation for 2 h in serum free conditions in U2OS cells
treated with siCtrl or siNMIIa (±s.e.m., n¼6 samples from two independent experiments). Scale bar 10 mm, 5 mm for insets. Student’s t-test, *Po0.05,
**Po0.01, ***Po0.001.
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Figure 2 | NMIIa colocalizes with actin on LDs and concentrates between dissociating LDs. (a) Stable U2OS Cherry-HPOS cells were treated with
400mM oleic acid overnight, saponin permeabilized, ﬁxed and immunostained for NMIIa. Deconvolved confocal images, scale bar 10mm, 2.5mm for inset.
(b) 3D-SIM of stable U2OS Cherry-HPOS cells treated and stained as in (a) including Alexa 488 Phalloidin to visualize actin. Scale bar 10mm, 0.5 mm for
insets. (c) Electron micrographs of U2OS cells treated with 400mM oleic acid overnight, immunostained with anti-NMIIa antibodies. Arrows indicate
NMIIa localisation, left panel: stress ﬁbres, middle panel: LD surface, right panel: between contacting LDs. Scale bar 200nm (d) Live cell Airyscan imaging
of U2OS cells transfected with GFP-NMIIa for 24 h and loaded with 400 mM oleic acid overnight. Frame rate 633ms, scale bar 1 mm. Arrows indicate
transient GFP-NMIIa accumulation between dissociating LDs (arrowheads). (e) Intensity line proﬁles to visualize transient GFP-NMIIa accumulation
between dissociating LDs at indicated times. This ﬁgure is accompanied by Supplementary Fig. 4a,b and Supplementary Movies 1 and 2.
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Fig. 7a–e). Of note, despite the clear reduction of NMIIa, actin
was not reduced in LD fractions of FMNL1-depleted cells
(Supplementary Fig. 7h), apparently reﬂecting the association
of also other actin populations, that do not contain NMIIa, to
LDs. Finally, FMNL1 depletion resulted in the formation
of enlarged LDs analogously to NMIIa depletion (Supplementary
Fig. 8a). This was observed despite the fact that FMNL1
depletion also inhibited fatty acid uptake, thereby lowering
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Figure 3 | Altered clustering and association kinetics of LDs in NMIIa-depleted cells. (a) Live cell CARS microscopy of U2OS cells treated either with
siCtrl or siNMIIa, and with oleic acid for overnight. Images were acquired every 2 s for 5min (scale bar 2 mm for upper panel, 2.5mm for lower panel).
Arrowheads indicate alternating LD associations (upper panel) and stable LD associations (lower panel). (b) Quantiﬁcation of LDs that stay associated
during 5min, for videos acquired as in a, oleic acid load was for 8 h to overnight. ±s.e.m., n¼ 3 independent experiments, at least 290 LD associations
were quantiﬁed per treatment. (c) Example of automated LD cluster detection (scale bar 2.5mm). Arrows indicate detected LD clusters. (d) Automated
LD cluster analysis of U2OS cells treated with siCtrl or siNMIIa, and oleic acid for 7 h. Cluster analysis was performed on the same image sets as in Fig. 1d.
Number of clusters detected per 100 LDs per cell were quantiﬁed for cluster sizes containing 2, 3, 4 and 5 LDs.±s.e.m. n¼ 3 independent experiments.
(e) Automated quantiﬁcation of mean LD size in clusters. (f) Automated quantiﬁcation of LD size heterogeneity in clusters (for e and f, ±s.e.m. n¼ 258
cells for siCtrl and 134 cells for siNMIIa, from three independent experiments). (g) Schematic representation for the quantiﬁcation of LD size heterogeneity
within clusters. (h) Quantiﬁcation of mean LD size in clusters in U2OS cells stably overexpressing (o.e.) Cherry or Cherry-NMIIa-siRes treated with siCtrl or
siNMIIa, and oleic acid for 8 h. Quantiﬁcation was performed from the same data set as in Supplementary Fig. 2e (±s.e.m., n¼ 224 cells for siCtrl U2OS
Cherry, 160 for siNMIIa U2OS Cherry, 206 for siCtrl U2OS Cherry-NMIIa siRes and 151 for siNMIIa U2OS Cherry-NMIIa siRes). (i) Quantiﬁcation of LD size
heterogeneity from the same data sets as in h. Student’s t-test *Po0.05, ***Po0.001.
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Figure 4 | FMNL1 localizes to LDs and coincides with LD dissociation sites. (a) Airyscan microscopy of stable U2OS Cherry-HPOS cells treated with
400mM oleic acid overnight, saponin permeabilized, ﬁxed and immunostained for FMNL1. Scale bar 10 mm, 2.5mm for inset. (b) 3D-SIM of stable U2OS
Cherry-HPOS cells treated and stained as in (a). Scale bar 1mm. (c) 3D-SIM of stable U2OS Cherry-HPOS cells treated with 400 mM oleic acid overnight,
saponin permeabilized, ﬁxed and immunostained for FMNL1 and myosin light chain. Scale bar 10mm, 1mm for inset. Arrows indicate close proximity of
FMNL1 and myosin light chain on LD surface. (d) Live cell Airyscan microscopy of GFP-FMNL1 and LDs in U2OS cells treated with 200 mM oleic acid
overnight, images were acquired every 925ms. Scale bar 0.5 mm. Arrow indicates GFP-FMNL1 accumulation between dissociating LDs (arrowheads).
(e) Live cell Airyscan microscopy of GFP-NMIIa and LDs in U2OS cells treated with 400mM oleic acid overnight, images were acquired every second. Scale
bar 0.5 mm. Arrow indicates GFP-NMIIa accumulation between dissociating LDs (arrowheads). (f) Quantiﬁcation of LD dissociation events positive for
FMNL1 or NMIIa from videos acquired as in (d,e). 155 LD dissociation events were assessed from 7 GFP-FMNL1/LD videos and 136 LD dissociation events
from 13 GFP-NMIIa/LD videos. (g) Timing of FMNL1 and NMIIa recruitment to LD dissociation sites. LD dissociation sites positive for FMNL1 or NMIIa
were assessed for whether FMNL1 or NMIIa associated with the site before or only during the dissociation event. The same datasets as in (f) was used for
quantiﬁcation. Student’s t-test **Po0.01. See also Supplementary Movies 8 and 9.
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TG storage (Supplementary Fig. 8b,c). Together, these data
suggest that FMNL1 mediates LD localisation of NMIIa,
possibly by generating speciﬁc actin ﬁlaments to which NMIIa
binds.
To provide more direct evidence for actin ﬁlament assembly on
LDs and the potential role of FMNL1 in this process, we designed
an in vitro assay, which allows the monitoring of actin
polymerisation on isolated LDs using total internal reﬂection
ﬂuorescence (TIRF) microscopy. LDs were isolated from
oleic acid-loaded U2OS cells, labelled with LipidTOX green,
and then mixed with rhodamine actin and unlabelled actin in
a TIRF reaction chamber (Fig. 6d). Actin ﬁlament assembly
was monitored by video TIRF microscopy (Fig. 6d,e). We found
that under these conditions B6% of isolated LDs associated
with actin ﬁlaments and displayed time-dependent growth of
actin ﬁlaments from them (Fig. 6e–g). That only a small fraction
of LDs displayed actin nucleation may result from partial
dissociation of FMNL1 from LDs during isolation or absence of
soluble FMNL1-interacting proteins in the in vitro system.
Thus, the process may be more efﬁcient in living cells. Addition
of the formin inhibitor SMIFH2 (ref. 22) or use of LDs isolated
from FMNL1-depleted cells in the in vitro assay blunted actin
ﬁlament association with LDs (Fig. 6g).
MYH9RD patient neutrophils display altered lipid storage.
Mutations in the human MYH9 gene cause a rare autosomal
dominant disorder generally referred to as MYH9-related
disease (MYH9-RD), with tens of individual disease causing
mutations identiﬁed23. MYH9-RD is characterized by NMIIa
inclusion bodies in neutrophilic leucocytes, thrombocytopenia
with giant platelets and multiorgan symptoms, including
800
0 sa
d
e
f
b c
0 s 54 s 158 s 280 s
LD
GFP-
FMNL1
BFP-
Lifeact
LD/
FMNL1
LD/
Lifeact
LD/
FMNL1/
Lifeact
LD
/F
M
N
L1
/
Li
fe
a
ct
G
FP
-
FM
N
L1
BF
P-
Li
fe
a
ct
LD
0.9 s
1.8 s
2.8 s
0.9 s
1.8 s
2.8 s
LD
FMNL1
Lifeact
LD
FMNL1
Lifeact
FMNL1
Lifeact
600
400
200
0
800
600
400
200
0
800
600
400
200
0
800
120
100
80
60
40
20
0
–20 100 200 300 s
600
400
200
0
0.4
t = 158 s
0 1 2 3 4 5 6 µm
In
te
ns
ity
 (a
.u.
)
In
te
ns
ity
 (a
.u.
)
R
el
at
ive
 in
te
ns
ity
in
cr
ea
se
 %
0.8 1.2 µm
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arrowheads indicate dissociating LDs. (c) Line proﬁles visualize the transient accumulation of FMNL1 and subsequent accumulation of Lifeact at the
dissociation site. (d) Live cell imaging of GFP-FMNL1, BFP-Lifeact and LDs in U2OS cells treated with 400 mM oleic acid overnight. Cells were switched to
growth medium for video acquisition, images were acquired every 2.59 s. Scale bar 2 mm. Arrows indicate transient accumulation of GFP-FMNL1 and BFP-
Lifeact between LDs. Arrowheads highlight dissociating LDs with light blue indicating the LD moving most relative to the others. (e) Line proﬁles
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between LDs throughout the video in the area indicated. See also Supplementary Movies 12 and 13.
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sensorineural hearing loss, renal failure and presenile cataract, the
pathogenesis of which are incompletely understood24.
To investigate whether cells from patients with MYH9-RD
display a LD-related phenotype, we isolated peripheral blood
neutrophilic leucocytes from two patients with MYH9-RD
carrying a point mutation in the C-terminal non-helical tail of
NMIIa (S. Ryha¨nen, personal communication) and two healthy
individuals. These patients present with marked macrothro-
mbocytopenia and several family members have been diagnosed
with hearing loss25, in accordance with the site of the mutation23.
By NMIIa immunostaining, the diagnostic NMIIa inclusion
bodies of the disease were evident and the overall NMIIa
immunoreactivity was decreased in the patient neutrophils
(Fig. 7a,b). Under basal conditions (fasting blood samples, no
lipid loading in vitro), both control and patient neutrophils
displayed few LDs (approximately seven LDs per cell) (Fig. 7c,d).
Remarkably, upon 1 h of oleic acid loading in vitro, LD accumu-
lation was more pronounced in the patients’ neutrophils,
resulting in roughly twofold more LDs compared with controls
(Fig. 7d,e). In parallel, there was a tendency for the enlargement
of LDs in the patients’ cells, especially in the bigger LD size classes
(Fig. 7e). Thus, the LD phenotypes in the patient neutrophils
appeared partly reminiscent of those observed in NMIIa-silenced
U2OS cells. Together, these ﬁndings provide the ﬁrst evidence
that NMIIa dysfunction in man causes a lipid imbalance,
possibly contributing to the pathogenesis of MYH9-RD. For
instance, neutrophil LDs can modulate the immune response, as
impaired LD lipolysis was found to be accompanied by reduced
lipid mediator release26.
Discussion
Actin-binding proteins are prominent constituents of the LD
proteome but their speciﬁc roles on LDs are not well understood.
In this study, we describe a functional interplay of the
actin-polymerising factor FMNL1 and NMIIa, a force generating
protein, in LD dynamics. NMIIa is generally known as a major
constituent of contractile stress ﬁbres, regulating cell
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migration and focal adhesion stability. NMIIa binds actin
ﬁlaments and ATP hydrolysis evokes a conformational change,
resulting in pulling along actin ﬁlaments and force generation27.
Recent evidence indicates that NMIIa can also act on specialized
actin ﬁlament structures, for instance, during mitochondrial
ﬁssion28.
We found that NMIIa transiently accumulates at sites where
LDs separate from one another. LDs are known to undergo
homotypic associations and dissociations, resulting in the
formation of dynamic LD clusters. Our data show that NMIIa
has a major impact on cellular LDs, with NMIIa depletion
resulting in enlarged LDs and increased TG storage owing
to impaired lipid breakdown. We postulate that impaired
dissociation/prolonged association of LDs enhances their coales-
cence, either via direct fusion (Supplementary Fig. 4e,f;
Supplementary Movie 7) and/or via lipid transfer5. This would
result in an increased size heterogeneity of LDs and a net
consumption of LDs within a cluster, with a concomitant
reduction of clusters. Indeed, NMIIa silencing reduced
LD dissociations. In parallel, the LD clustering propensities
were altered: there were fewer LD clusters and in these big
LDs often associated with small ones. This is strikingly different
from control cells where similarly sized LDs formed clusters.
NMIIa requires a preformed actin ﬁlament to exert its
function. But how could an actin ﬁlament be generated at
LD dissociation sites? We demonstrate that FMNL1, a protein
with actin polymerisation activity, localizes to LD dissociation
sites. It can thus provide a seed for acto-myosin assembly,
as depletion of FMNL1 abolishes NMIIa association with
LDs. Furthermore, we found that isolated LDs have the ability
to induce actin ﬁlament assembly in vitro. This activity was
dependent on FMNL1, as pharmacological inhibition of formins
or depletion of FMNL1-blunted actin ﬁlament assembly on
isolated LDs. Based on these observations, we suggest that
FMNL1 localizes to LD dissociation sites to nucleate actin
ﬁlaments that are functionalized by NMIIa, providing a force to
assist in LD dissociation. This idea is supported by the temporal
association of the actin-binding proteins with LDs, with FMNL1
accumulation typically occurring between closely apposed
LDs before dissociation, potentially deﬁning LD dissociation
sites. Although most dissociating LDs also harbour NMIIa, it may
also be recruited to the site once LDs are moving apart.
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Considering that LDs also undergo rapid reassociations, an
alternative, although not mutually exclusive explanation is that
FMNL1, in concert with actin and NMIIa, prevents the
reassociation and fusion of LDs. Both mechanisms, promotion
of LD dissociation and prevention of LD reassociation, highlight
the importance of LD dynamics in controlling the coalescence
and surface to core ratio of LDs, and thereby the accessibility of
modifying enzymes to core TGs.
Methods
Antibodies, dyes and reagents. Rabbit anti-NMIIa (Covance, PRB-440P
Immunoﬂuorescence (IF) 1:500, Immunoblot (IB) 1:3,000), mouse anti-alpha
tubulin (Sigma Aldrich, T6074, IB 1:20 000), rabbit anti-FMNL1 (Sigma Aldrich,
HPA008129, IB 1:1,000), rabbit anti-FMNL1 (D. Billadeau, Mayo Clinic, Rochester,
Minnesota, IF 1:50)21, mouse anti-myosin light chains (Sigma Aldrich, M4401,
IF 1:200), Alexa488 goat anti-rabbit, A11008; Alexa568 goat anti-rabbit, A11011;
Alexa647 donkey anti-rabbit, A31573 (all Thermo Fisher, 1:200); HCS LipidTOX
green neutral lipid stain, H34475, (live cell 1:1,000, ﬁxed cells 1:100) HCS
LipidTOX deep red neutral lipid stain, H34477, (live cell 1:5,000  1:10,000),
Alexa488 Phalloidin, A12379, (132 nM) all Thermo Fisher, LD540 (Princeton
BioMolecular Research, 0,1 mgml 1); Cell culture reagents and general reagents
were purchased from GibCo/Thermo Fisher, Lonza and Sigma-Aldrich.
Lipoprotein-deﬁcient serum has been made from fetal bovine serum (FBS) as
described previously29.
siRNAs, plasmids and mutagenesis. SiRNAs targeting NMIIA and FMNL1 were
purchased from Qiagen and control siRNA from Sigma-Aldrich. Target sequence
siControl: 50-CGTACGCGGAATACTTCGA-30 (ref. 30); siNMIIa: 50-TCGGAGC
ACAAGCGCAAGAAA-30 ; siNMIIa-2: 50-CACGGAGATGGAGGACCTTAT-30 ,
siFMNL1: 50-TCCGCTGTGGCCCGCCTCAAA-30 , siTM4: 50-AATTAAACT
TCTGTCTGACAA-30 (ref. 17), eGFP-C3-NMIIa was reported previously31
(Addgene ID 11348). To generate mCherry-C3-NMIIa, mCherry was ﬁrst PCR
ampliﬁed from pmCherry-C1 using the following oligonucleotides CherryFW:
50-GAGAGCTAGCGCTACCGGTCGC-30 and CherryBW: 50-TCCTAGATC
TGAGT-ACTTGTACAGCTCGTCCATGC-30 , and used to replace eGFP in eGFP-
C3 via NheI and BglII restriction sites to generate a pmCherry-C3 vector. NMIIa
was shuttled from eGFP-C3-NMIIa to pmCherry-C3 using HindIII and SalI sites.
For generation of siRNA-resistant NMIIa we ﬁrst generated two PCR fragments
including the siRNA resistant sequence in the corresponding -30 and 50-
oligonucleotides. PCR oligonucleotides for 1st fragment: NMIIa5Prime: 50-GAG
AAAGCTTATGGC ACAGCAAGCTG-30 ; 3Prime-siRNA-NMIIA: 50-CTTTTTCC
GTTTATGTTCGGAGTCCCCTTTGCCCTGCAGCAG-30 , PCR oligonucleotides
for the 2nd fragment: 5Prime-siRNA-NMIIa: 50-TCCGAACATAAACGGAAA
AAGGTGGAGGCGCAGCTGCAGG-30; NMIIa-3Prime-EcoR1: 50-GAGAGAAT
TCTTCTCGTCCTCCACCTG-30 . The fragments were used as template for
ampliﬁcation of an siRNA resistant N-terminal NMIIA fragment using
NMIIa5Prime and NMIIa-3Prime-EcoRI oligonucleotides. This was inserted into
GFP-NMIIa via HindIII and EcoRI restriction sites to generate GFP-NMIIa-siRes.
NMIIa siRes was transferred from GFP-NMIIa to mCherry-C3 to generate
mCherry-NMIIa-siRes. For the generation of Cherry-HPOS, oligonucleotides
encoding the HPOS sequence18 with a 50 BspEI restriction site 50-TCCGG
AATGGATGTCCTGGTTCCATTGCTGCAGCTGCTGGTGCTGCTCCTGAC
TCTGCCTTTACAC-CTGCTGGCTCTGCTGGGCTGCTGGCAGCCCCTCTT
TGAAGCGATTGGCAAGATATTCAGCAATATCC-GCATCAGCACGCAGA
AAGAGATATGA-30 were synthesized, annealed and inserted into pmCherry-C1
via BspEI and SmaI restriction sites. We obtained the cDNA for FMNL1 alpha
from D. Billadeau21, PCR ampliﬁed it with the oligonucleotides: FMNL1FWNhe1:
50-GAGAGCTAGCATGGGCAACGCGGCCGGCA-30 and FMNL1BWBamH1:
50- GAGAGGATCCCGGAGGGGCATCTCTTCTCCCA-30 and cloned into
peGFP-N1 via Nhe1 and BamH1 restriction sites. BFP-actin was generated
by replacing GFP of GFP-actin with mTagBFP2 from pmTagBFP2-C1
(from V. Verkhusha) using Nhe1 and Bgl2 restriction sites. BFP-LifeAct was
obtained by replacing the GFP-sequence of LifeAct-GFP with mTagBFP2 from
pmTagBFP2-N (from V. Verkhusha) via BamH1 and Not1 restriction sites.
Cell culture and transfection. U2OS cells kindly provided by Marikki Laiho
(John Hopkins University, USA) were cultured in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) with 15% FBS, supplemented with penicillin/streptomycin
(100Uml 1 each) and L-glutamine (2mM). Stable U2OS Cherry-NMIIa,
Cherry-NMIIa-siRes and Cherry-HPOS cell lines were selected with 500–600 mg
G418 per ml culture medium. SiRNA treatments were performed for 48 or 72 h
using Hiperfect (Qiagen) or RNAiMax (Thermo Fisher) using reverse transfection
with 50 nM siRNA. Oleic acid loading was performed during the siRNA treat-
ments. Plasmids were transfected using Lipofectamine LTX (Thermo Fisher)
with the PLUS (Thermo Fisher) reagent. Cells were tested for Mycoplasma
infection.
LD isolation and mass spectrometry. Raw 264.7 cells (received from Vesa
Olkkonen, Minerva Foundation Institute for Medical Research, Helsinki, Finland)
were cultured in DMEM with 10% FBS, 10mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES), L-glutamine (2mM) and penicillin/strepto-
mycin (100Uml 1). Cells were treated with 400 mM oleic acid or 35mgml 1
acetylated low density lipoprotein in DMEM with 5% lipoprotein deﬁcient
serum for 24 h. LD isolation was performed similar to previously described32.
The treatments were combined for LD isolation to maximize the yield.
Cells were washed with cold phosphate buffered saline (PBS) and resuspended
in 3.5ml hypotonic lysis buffer (HLM; 20mM Tris pH 7.4, 1m M
ethylenediaminetetraacetic acid), and incubated on ice for 10min. Cells were
disrupted by repetitive passaging through a 25 g needle, 3ml of cell suspension was
transferred to a Beckmann polyallomer tube (14 95mm) (No. 331374) and
mixed with 1.5ml 60% sucrose solution, overlayed with 4ml 5% sucrose solution
and 4ml HLM Buffer. Samples were centrifuged at 28,000 g with a SW40 rotor for
2 h. The LD fraction was recovered by tube slicing and subjected to liquid
chromatography–mass spectrometry (LC-MS/MS). For LC-MS/MS, the samples
were prepared as follows: the cysteine bonds were reduced with 5mM TCEP
(Sigma–Aldrich), alkylated with 10mM iodoacetamide (Sigma–Aldrich), and the
proteins were digested to peptides by trypsin (Promega, Madison, WI). After
overnight incubation at 37 C, samples were quenched with 10% TFA, puriﬁed with
C18 Micro SpinColumns (Harvard Apparatus, Holliston, MA) and re-dissolved in
30 ml 0.1% TFA, 1% CH3CN. The LC-MS/MS analysis was carried out on an
EASY-nLCII nanoﬂow system (Thermo Scientiﬁc) connected to a Velos
Pro-Orbitrap Elite hybrid mass spectrometer (Thermo Scientiﬁc) using the
Xcalibur version 2.7.1. The peptides were separated using 10 cm analytical column
(Thermo Fisher Scientiﬁc) with 60min gradient ranging from 5 to 35% buffer B
(0.1% formic acid in 98% acetonitrile and 2% water), followed by a 5min gradient
from 35–80% buffer B and 10min gradient from 80–100% buffer B at a ﬂow rate
of 300 nlmin 1. Proteome Discoverer software (Thermo Scientiﬁc) together with
SEQUEST search engine was used for peak extraction and subsequent peptide
and protein identiﬁcation. Error tolerances on the precursor and fragment ions
were 15 ppm and 0.6Da, respectively. Database searches were limited to fully
tryptic peptides with maximum one missed cleavage. For peptide identiﬁcation
the FDR was set to o5%.
LD isolation and actin assembly on isolated LDs. U2OS cells (6–7 10 cm dishes)
were treated overnight with 400 mM oleic acid in culture medium. EDTA in
HLM buffer was replaced with EGTA. LD isolation was performed as described
above and LD fractions were retrieved from the top with a 1ml pipette. In vitro
TIRF imaging was performed as previously described33, but muscle actin was
substituted with non-muscle actin (Cytoskeleton Inc.), prepared according to the
manufacturer’s instructions, and non-muscle rhodamine actin (Cytoskeleton Inc.)
was used for labelling of the ﬁlaments. Videos were obtained with 0.15 mM
unlabelled non-muscle actin, 0.065mM rhodamine non-muscle actin and 0.43 mM
proﬁlin concentrations. Proﬁlin was puriﬁed from cow spleen as previously
described34 SMIFH2 formin inhibitor22 (Sigma-Aldrich) was used at 100 mM.
TIRF imaging was performed in mPEG-Silane (MW 5k)-coated chambers with
a Nikon Eclipse Ti-E N-STORM microscope, equipped with Andor iXonþ 885
EMCCD camera and  100 Apo TIRF oil objective NA 1.49, a 561 nm laser line
was used for visualisation of Rhodamine actin. Actin ﬁlament polymerisation
was followed in 0.1 s intervals for 15min after addition of the reaction into the
imaging chamber.
LD preparation for western blot analysis. U2OS Cherry-HPOS cells were seeded
in 2–4 10 cm dishes and transfected with siControl or siFMNL1. After 24 h cells
were incubated with 400 mM oleic acid in control medium for an additional 24 h.
Cells were washed 2 with Dulbecco’s phosphate-buffered saline (DPBS) and
then scraped into 5ml DPBS. Cells were pelleted by centrifugation at 730 g for
5min and resuspended in 900ml HLM buffer. Cells were broken by repetitive
passaging through a 25 g needle, and 750ml of the suspension was mixed with
750 ml HLM buffer with 60% sucrose, overlayed with 1ml HLM with 5% sucrose
followed by 1.5ml HLM buffer. LDs were ﬂoated by centrifugation at 28,000 g for
2 h in a SW60 rotor. Of the LD fraction, 10% was removed for lipid determination
and the rest was subjected to acetone precipitation with 10 volume of  75 C
acetone. Samples were incubated at  20 C degree overnight and centrifuged at
3,300 g for 100min. Proteins were resuspended in 2 loading buffer by sonication
and subjected to western blot analysis. Original scans of the respective western
blots shown in Fig. 6a can be found in Supplementary Fig. 9.
Automated LD analysis. U2OS cells were cultured on coverslips or 96 well
Screenstar plates (Greiner) and incubated with or without oleic acid for 7 h. Cells
were treated with 2 mM CellTracker Red for 30min to 1 h in culture medium with
or without oleic acid, washed 3with PBS and ﬁxed with 4% paraformaldehyde in
250mM HEPES, 1000mM CaCl, 100mM MgCl, pH 7.4. Cells were washed 3
with PBS and stained with 1 mM 40 ,6-diamidino-2-phenylindole (DAPI) and
100 ngml 1 LD540 (or 1:1,000 LipidTox green) in PBS for 30min at room tem-
perature (RT), washed 3 with PBS and mounted with PBS and epoxy glue. For
every treatment 10 image stacks were acquired for DAPI, LD and cell tracker
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channels using a Nikon Eclipse Ti-E inverted microscope equipped with a 60
PlanApo VC oil objective NA 1.40 (or 40 Planﬂuor objective with NA 0.75 and
1.5 zoom). Image stacks were automatically deconvolved using the Huygens batch
processing application (Scientiﬁc Volume Imaging) and deconvolved image stacks
were transformed into maximum projection images using custom MatLab scripts.
Cell segmentation and LD detection was performed with CellProﬁler 1.0.5122
(CellProﬁler.org)35 in a hierarchical manner. First, cell nuclei with a typical
diameter between 100 and 250 pixels were detected in DAPI images based on the
Otsu adaptive thresholding method. Touching nuclei were separated by build in
intensity methods. Second, the cytoplasm was detected in CellTracker Red images
using intensity propagation based on the Otsu global thresholding method using
the identiﬁed nuclei from the ﬁrst step as a seed point. Third, LDs were
detected using a combination of a A-trous spot detection method with Otsu
adaptive thresholding, enabling the detection of small and large LDs separately.
The detected LDs were further processed with custom Matlab scripts, which
corrected for large LDs misclassiﬁed as several small LDs. Furthermore, the
custom Matlab scripts contained an algorithm to identify clustered LDs. Data
visualisation was done using Excel and Origin 8.6.
Lipid extraction, analysis and TG hydrolysis. Lipid extraction was performed
as described previously36. Cells were washed 3 with PBS and scraped into
2% sodium chloride and lipids were extracted with chloroform methanol in
a 2:1 ratio. Solvents were evaporated and lipids dissolved in 2:1 chloroform:
methanol for application to thin layer chromatography (TLC). TLC was performed
with hexane:diethylether:acetic acid 80:20:1. TLC plates were stationed with
copper sulfate and developed by charring. TG content was quantiﬁed and
normalized to protein content measured by Bio-Rad protein determination. For
the TG hydrolysis assay, siCtrl- and siNMIIa-treated U2OS cells were loaded with
200mM oleic acid for 24 h, with or without inhibition of cholesterol ester synthesis
with Sandoz-58-035. Cells were washed with PBS and incubated with U2OS growth
medium for 8 h. Lipids were extracted before or after the 8 h chase in normal
growth medium. TG content was quantiﬁed and used to calculate the percent
decrease in TG before the 8 h chase. In cells treated with control siRNA TGs were
reduced on average by 45% during the 8 h chase.
TG synthesis and fatty-acid uptake. U2OS cells were treated with NMIIa or
control siRNA for 48 h. Cells were washed 3 with PBS and then treated with
3H-oleic acid (Perkin Elmer) in DMEM plus 2% fatty acid-free bovine serum
albumin for 2 h at 37 C. Cells were washed 3 with PBS, lipids were extracted
and neutral lipids resolved by TLC. TGs were scraped into scintillation solution
and radioactivity was measured. Counts were normalized to an internal standard
and protein content. For fatty-acid uptake, experiments cells were treated with
3H-oleic acid in U2OS growth medium for 15min. Cells were washed 3 with
PBS and cell extracts were made in 2% NaCl. Radioactivity of the cell lysate was
measured with scintillation counting and normalized to protein content.
Western blot analysis. Cells were washed 3 with PBS and lysed with
Tris-buffered saline (TBS)/1% Triton X-100. Lysates were incubated on ice
for 10min, vortexed and centrifuged for 10min at 16,000 g at 4 C. Cleared
supernatants were mixed with loading buffer (50mM Tris pH 6.8, 2% sodium
dodecyl sulphate (SDS), 1% b-mercaptoethanol, 5% glycerol, ﬁnal concentrations)
and equal protein amounts were separated on SDS-polyacrylamide gels and
transferred to Immobilon polyvinylidene ﬂuoride (Millipore) membranes. For
Odyssey antibody detection, blots were blocked with Odyssey Blocking buffer/PBS
(1:1) overnight at RT. Primary antibodies were diluted in Odyssey Blocking
Buffer/PBS with 0.1% Tween and incubated for 2 h at RT. Blots were washed with
TBS/0.1% Tween and incubated with secondary antibodies in Odyssey Blocking
Buffer/PBS with 0.1% Tween and 0.01% SDS for 30min at RT. Blots were washed
with TBS/0.1% Tween and PBS and scanned with an Odyssey CLx detection
system. For enhanced chemiluminescence (ECL) detection blots were blocked with
TBS/0.1% Tween with 5% skim milk for 2 h at RT. Primary antibodies were diluted
in blocking buffer and incubated overnight at 4 C. Blots were washed with
TBS/0.1% Tween and incubated with secondary antibodies in blocking buffer
for 30min. Blots were washed with TBS/0.1% Tween, PBS and distilled water.
ECL was performed with Clarity Western ECL substrate (Bio-Rad).
Quantitative PCR. RNA was puriﬁed from cells using a Nucleospin RNA isolation
kit (Macherey-Nagel) following the manufacturer’s protocol and reverse tran-
scribed with a SuperScript VILO cDNA synthesis kit (Thermo Fisher Scientiﬁc).
Real-time PCR was performed with Lightcylcer 480 SYBR Green master mix
(Roche Diagnostics), 250 nM oligonucleotides and 64 C annealing temperature.
GAPDH FW: 50-GAAGGTGAAGGTCGGAGTC-30 GAPDH BW: 50-GAAGATG
GTGATGGGATTTC-30 ; FMNL1 QFW1: 50-CTCAGGAGGCCTTTGAGTCTG-30 ;
FMNL1 QBW1: 50-ACCTCCTGCTCAGCTTTCTTGTA-30 .
IF staining using pre-ﬁxation permeabilization. U2OS Cherry-HPOS cells were
seeded on ﬁbronectin coated cover slips and incubated overnight with 400 mM
oleic acid. Cells were washed with DPBS, permeabilized with 0.005% saponin in
cyto-buffer (10mM MES pH 6.1, 138mM KCl, 3mM MgCl2, 2mM EGTA
and 320mM sucrose) for 1min, washed once with cyto-buffer and ﬁxed with
cytoskeleton preservation ﬁx (2.6% paraformaldehyde in 160mM HEPES, 64 mM
CaCl2, 67mMMgCl2, 10mMMES pH 6.1, 138mM KCl, 2mM EGTA and 320mM
sucrose) for 30min. Cells were washed with cyto-buffer, quenched with 50mM
NH4Cl in cyto-buffer for 5min, washed with cyto-buffer and blocked with
0.2% BSA in cyto-buffer (blocking buffer) for 10min at RT. Primary antibody
incubations were done in blocking buffer for 1 h at RT, followed by three washes
with cyto-buffer for 5min. Secondary antibody was diluted in blocking buffer
and incubated for 45min at RT. Cell were washed 3 5min with cyto-buffer
and mounted with MOWIOL/DAPCO for confocal or Airyscan microscopy
or with ProLong Diamond for 3D-SIM microscopy.
IF staining using post-ﬁxation permeabilization. Cells were ﬁxed with
4% paraformaldehyde in 250mM HEPES, pH 7.4, 100 mM CaCl2 and 100 mM
MgCl2 for 15min or cytoskeleton preservation ﬁx for 15–30min. Cells were
quenched with 50mM NH4Cl for 10min and permeabilized with PBS/0.1% Triton
X-100 for 5min. Cells were blocked with 10% FBS in PBS for 30min at 37 C.
Primary antibodies were diluted in blocking solution and incubated for 45min
at 37 C. Cells were washed 3 with PBS and incubated with anti-rabbit
Alexa 546 or Alexa 647 in PBS/0.1% Tween in the presence or absence of Alexa 488
Phalloidin for 45min at 37 C. Cells were washed 3 with PBS and mounted with
Mowiol/DAPCO.
Confocal and superresolution light microscopy. For confocal microscopy,
cells were imaged using a Leica TCS CARS SP8 confocal microscope with
a 63 HC PL APO CS2 glycerol objective NA 1.3. or a Zeiss LSM 880 confocal
microscope using a 63 Plan-apochromat oil objective, NA 1.4. For Airyscan
superresolution microscopy, cells were imaged with a Zeiss LSM 880 equipped with
an Airyscan detector using a 63 Plan-apochromat oil objective, NA 1.4.
The Airyscan detector was adjusted before each image or video acquisition and
images were Airyscan processed using the Zeiss Zen software package. 3D-SIM
was performed on a Deltavision OMX V4 microscope (Applied Precision,
GE Healthcare) equipped with an Olympus 60x Plan Apochromat objective
NA 1.42, 488, 568 and 642 nm laserlines, and three cooled sCMOS cameras.
z-Stacks covering the whole cell were recorded, with a z-spacing of 125 nm. For
each focal plane, 15 raw images (ﬁve phases for three different angular orientations
of the illumination pattern) were captured. Superresolution images were
reconstructed, aligned, and processed for presentation using Softworx software
(Applied Precision, GE Healthcare). Brightness and contrast were adjusted
with ImageJ, please note that cropped areas may have different intensity
adjustments than the corresponding larger cell views. Localisation of NMIIa at
LDs was assessed in 11 independent experiments; localisation of NMIIa at
LDs upon FMNL1 depletion in three independent experiments; colocalisation of
NMIIa and phalloidin at LDs in eight independent experiments; FMNL1 locali-
sation at LDs in eight independent experiments; localisation of FMNL1 and
myosin light chain at LDs in three independent experiments; localisation of
myosin light chain at LDs in ﬁve independent experiments.
Quantiﬁcation of NMIIa and FMNL1 localisation at LDs. Confocal image stacks
of U2OS Cherry-HPOS cells stained with anti-FMNL1 or anti-NMIIa antibodies
were deconvolved using Huygens deconvolution software. NMIIa and FMNL1
patches with a preset minimum intensity were counted at LDs with a diameter of
Z1 mm by inspecting each individual section of a z-stack. On average, 10 LDs were
counted per cell. NMIIa or FMNL1 patches, which associated with two
neighbouring LDs were counted as patches at LD contact sites.
Live cell imaging. U2OS cells were seeded in LabTEK chamber slides coated with
5 mg human ﬁbronectin (Roche Diagnostics). Cells were treated with 200– 400 mM
oleic acid for 8 h or overnight. Cells were imaged in fresh culture medium or
culture medium containing oleic acid including 10mM HEPES pH 7.3. LDs were
stained either with LipidTOX green or LipidTOX deep red. Live cell microscopy
was performed with a Leica TCS SP8 confocal microscope or a LSM880 confocal
microscope with an Airyscan module. Live cell microscopy for ﬂuorescently tagged
NMIIa at LDs was performed in nine independent experiments; GFP-FMNL1
at LDs in four independent experiments; GFP-FMNL1 with BFP-Lifeact at
LDs in six independent experiments and BFP-Lifeact/BFP-actin at LDs in four
independent experiments. LD dynamics with blebbistatin was assessed in four
independent experiments and with cytochalasin D in one experiment.
CARS microscopy. CARS microscopy is a non-linear label-free imaging method
especially well suited for LD imaging37,38. CARS video microscopy was done
with non-labelled cells by adjusting pump and stokes laser to the vibration
frequency of C-H groups (2845 cm 1). An infrared corrected 25 objective
(HCX IR APO L, NA 0,95) was used for CARS image acquisition. Images were
acquired every 2 s over a time course of 5min. Live cell CARS microscopy
for LD association dynamics was assessed in three independent experiments
(Fig. 3a,b, Supplementary Movie 4).
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Pre-embedding immuno-EM. U2OS cells were loaded with 400 mM oleic
acid overnight and ﬁxed with 4% paraformaldehyde in MES-sucrose buffer
(10mM MES/138mM KCl/3mM MgCl2/2mM EGTA/11.14% sucrose) for 2 h.
The cells were then permeabilized with 0.01% saponin in 0.1% BSA/0.1 M
Na-PO4 pH 7.4 for 8min, labelled with the rabbit anti-NMIIa antibody
(Covance, PRB-440 P 1:50) for 2 h followed by the nano-gold-conjugated
anti-rabbit Fab-fragments for 1 h (Nanoprobes, #2004, 1:60), post-ﬁxed in
10% glutaraldehyde, and quenched in 50mM glycine. The nano-gold particles were
intensiﬁed using the HQ SILVER Enhancement kit according to the manufacturer’s
instructions (Nanoprobes) followed by gold toning in subsequent incubations
in 2% NaAcetate, HAuCl4 and 0.3% Na2S2O35H2O. The cells were treated with
1% OsO4 supplemented with 15mgml 1 K4[Fe(CN)]6 and ﬂat-embedded in
Epon as described earlier39. Ultrathin sections were cut using Leica UCT
microtome, picked on pioloform coated single slot grids, post-stained with
uranyl acetate and lead citrate, and observed with the Jeol JEM-1400 microscope
at 80 kV. Images were acquired with the Gatan Orius SC 1000B camera.
Neutrophil isolation and lipid loading. Freshly isolated peripheral blood from
MYH9-RD patients and from healthy individuals was used for neutrophil isolation
using Polymorphprep (Axis-Shield) and contaminating erythrocytes were lysed
using 155mM NH4Cl, 12mM NaHCO3, 0.1mM EDTA. Neutrophils were
resuspended in Hank’s balanced salt solution without calcium and magnesium and
adhered to poly-D-lysine-coated cover glasses for 15min or transferred to 24 well
plates with poly-D-lysine-coated cover glasses and incubated with 10 mM oleic acid
for 1 h at 37 C. Neutrophils were ﬁxed with 4% paraformaldehyde and subjected
to NMIIa or LD stainings. Neutrophils were imaged with a Nikon Eclipse
Ti-E N-STORM microscope, equipped with a 100Apo TIRF oil objective
NA 1.49. LD images were automatically deconvolved using Huygens software
(Scientiﬁc Volume Imaging). Maximum intensity projections were generated
using MatLAB and thresholded LD images were quantiﬁed using the ImageJ
analyse particles tool. The MYH9-RD patients provided a written informed
consent in accordance with the Declaration of Helsinki.
Data analysis. Data are presented as mean±s.e.m. Statistical signiﬁcance was
calculated with students t-test (two tailed) using Microscoft Excel.
Code availability. Matlab scripts and corresponding CellProﬁler analysis pipelines
(CellProﬁler 1.0.5122, www.cellproﬁler.org) for automated LD analysis can be
obtained from Peter Horvath (peter.horvath@brc.mata.hu).
Data availability. The data that support the ﬁndings of this study are available in
the article, including Supplementary Files, or are available from the authors upon
reasonable request.
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